These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8366988)

  • 21. Angiotensin II and renal prostaglandin release in the dog. Interactions in controlling renal blood flow and glomerular filtration rate.
    Bugge JF; Stokke ES
    Acta Physiol Scand; 1994 Apr; 150(4):431-40. PubMed ID: 8036911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of angiotensin II on pressure natriuresis and renal hemodynamics in volume-expanded rats.
    Mattson DL; Raff H; Roman RJ
    Am J Physiol; 1991 Jun; 260(6 Pt 2):R1200-9. PubMed ID: 2058747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of mesangiolysis on autoregulation of renal blood flow and glomerular filtration rate in rats.
    Iversen BM; Kvam FI; Matre K; Mørkrid L; Horvei G; Bagchus W; Grond J; Ofstad J
    Am J Physiol; 1992 Mar; 262(3 Pt 2):F361-6. PubMed ID: 1348397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The synthetic triterpenoid, RTA 405, increases the glomerular filtration rate and reduces angiotensin II-induced contraction of glomerular mesangial cells.
    Ding Y; Stidham RD; Bumeister R; Trevino I; Winters A; Sprouse M; Ding M; Ferguson DA; Meyer CJ; Wigley WC; Ma R
    Kidney Int; 2013 May; 83(5):845-54. PubMed ID: 23235569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late angiotensin II receptor blockade in progressive rat mesangioproliferative glomerulonephritis: new insights into mechanisms.
    Villa L; Boor P; Konieczny A; Kunter U; van Roeyen CR; Denecke B; Gan L; Neusser MA; Cohen CD; ; Eitner F; Scholl T; Ostendorf T; Floege J
    J Pathol; 2013 Apr; 229(5):672-84. PubMed ID: 23192593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis.
    Tesch GH; Lan HY; Atkins RC; Nikolic-Paterson DJ
    Am J Pathol; 1997 Jul; 151(1):141-50. PubMed ID: 9212740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Inhibition of mesangial cell proliferation and mesangial matrix expansion by antisense oligodeoxynucleotide targeting preproendothelin-1 mRNA in vivo].
    Li M; Chen Y; Zhang Z
    Zhonghua Yi Xue Za Zhi; 1999 Feb; 79(2):133-5. PubMed ID: 11601021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The antagonistic effect on anti-thy-1 serum-induced nephritis of rats injected by decorin-transfected mesangial cells vector].
    Wang HJ; Zhang ZG; Liu XG; Zhang XR; Chen Q; Guo MY
    Zhonghua Bing Li Xue Za Zhi; 2003 Oct; 32(5):444-8. PubMed ID: 14633458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TP receptors regulate renal hemodynamics during angiotensin II slow pressor response.
    Kawada N; Dennehy K; Solis G; Modlinger P; Hamel R; Kawada JT; Aslam S; Moriyama T; Imai E; Welch WJ; Wilcox CS
    Am J Physiol Renal Physiol; 2004 Oct; 287(4):F753-9. PubMed ID: 15213069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
    Rost S; Daniel C; Schulze-Lohoff E; Bäumert HG; Lambrecht G; Hugo C
    Kidney Int; 2002 Nov; 62(5):1659-71. PubMed ID: 12371966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered renal vascular responses in the aging rat kidney.
    Tank JE; Vora JP; Houghton DC; Anderson S
    Am J Physiol; 1994 Jun; 266(6 Pt 2):F942-8. PubMed ID: 8023973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel, dual role of CCN3 in experimental glomerulonephritis: pro-angiogenic and antimesangioproliferative effects.
    van Roeyen CR; Boor P; Borkham-Kamphorst E; Rong S; Kunter U; Martin IV; Kaitovic A; Fleckenstein S; Perbal B; Trautwein C; Weiskirchen R; Ostendorf T; Floege J
    Am J Pathol; 2012 May; 180(5):1979-90. PubMed ID: 22538190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelin-A receptors mediate renal hemodynamic effects of exogenous Angiotensin II in humans.
    Montanari A; Biggi A; Carra N; Ziliotti M; Fasoli E; Musiari L; Perinotto P; Novarini A
    Hypertension; 2003 Oct; 42(4):825-30. PubMed ID: 12925560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship among altered glomerular barrier permselectivity, angiotensin II, and mesangial uptake of macromolecules.
    Keane WF; Raij L
    Lab Invest; 1985 Jun; 52(6):599-604. PubMed ID: 4010224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction between angiotensin II and nitric oxide in control of renal hemodynamics in conscious dogs.
    Alberola AM; Salazar FJ; Nakamura T; Granger JP
    Am J Physiol; 1994 Dec; 267(6 Pt 2):R1472-8. PubMed ID: 7810755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of mesangial cell in glomerular response to volume and angiotensin II.
    Blantz RC; Gabbai FB; Tucker BJ; Yamamoto T; Wilson CB
    Am J Physiol; 1993 Jan; 264(1 Pt 2):F158-65. PubMed ID: 8430826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies of the renal component of the hypertension in rats with aortic constriction. Role of angiotensin II.
    Sahlgren B; Eklöf AC; Aperia A
    Acta Physiol Scand; 1986 Aug; 127(4):443-8. PubMed ID: 3529826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. L-Arginine supplementation increases mesangial cell injury and subsequent tissue fibrosis in experimental glomerulonephritis.
    Peters H; Border WA; Noble NA
    Kidney Int; 1999 Jun; 55(6):2264-73. PubMed ID: 10354274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of renal arterial endothelin-1 and endogenous endothelins on regional kidney blood flow and renal antihypertensive mechanisms in anesthetized rabbits.
    Weekes SR; Madden AC; Bergström G; Anderson WP; Evans RG
    Kidney Blood Press Res; 2000; 23(6):366-75. PubMed ID: 11070416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with Roscovitine, a novel cyclin-dependent kinase antagonist.
    Pippin JW; Qu Q; Meijer L; Shankland SJ
    J Clin Invest; 1997 Nov; 100(10):2512-20. PubMed ID: 9366565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.